
Loading, please wait...

Loading, please wait...

Recent research suggests that managing daytime outdoor activities is crucial to mitigate biological age acceleration. While health experts often advocate for increased sun exposure, a recent study indicates that both excessive and insufficient time spent outdoors can negatively impact aging biomarkers. By analyzing large-scale data from the UK Biobank, researchers have identified specific durations that optimize physiological health across different seasons. Consequently, finding a balance is essential for promoting longevity and healthy aging.
The study utilized the Klemera-Doubal method (KDM-BA) and phenotypic age (PhenoAge) to evaluate biological aging. Specifically, the optimal time spent outdoors for the lowest KDM-BA acceleration reached two hours per day during the summer. In contrast, during the winter months, the optimal duration dropped to just one hour. For PhenoAge, the ideal duration remained consistently one hour longer in both seasons. Therefore, clinicians should consider these seasonal variations when advising patients on lifestyle habits.
Moreover, the relationship between outdoor time and aging follows a non-linear pattern. Both KDM-BA and PhenoAge acceleration increased when participants stayed outdoors longer than the identified optimal times. This suggests that excessive UV exposure or environmental stressors might counteract the benefits of being outside. On the other hand, spending too little time outdoors also correlated with faster aging, particularly for PhenoAge markers in both seasons. Thus, a moderate approach is most beneficial.
Furthermore, these findings emphasize that appropriate daytime activity plays a significant role in biological age acceleration. Spending less than the optimal hour in winter specifically links to increased KDM-BA acceleration. However, this negative association appeared less pronounced during the summer months. These insights allow for more personalized recommendations. For instance, doctors can suggest shorter outdoor intervals in winter to maintain circadian rhythms without unnecessary cold exposure.
In addition, maintaining a balanced lifestyle includes monitoring how environmental factors interact with our internal biological clocks. Since accelerated aging increases the risk of chronic diseases, these findings are highly relevant for geriatric care and general practice. By optimizing outdoor exposure, individuals may effectively slow down their biological clock. Consequently, public health guidelines should evolve to include these nuanced, season-specific recommendations.
KDM-BA and PhenoAge are two distinct metrics used to estimate biological age. KDM-BA focuses on physiological biomarkers like blood pressure and cholesterol, while PhenoAge incorporates markers related to mortality risk and systemic inflammation. Both help identify biological age acceleration, which occurs when a person's biological age is higher than their chronological age.
The optimal time changes due to variations in UV intensity and environmental temperature. In summer, higher UV levels provide sufficient vitamin D synthesis more quickly, but excessive exposure can lead to oxidative stress. In winter, limited sunlight requires more intentional exposure to maintain health, yet extreme cold may also impact the body's aging processes.
Yes, the study found that spending time outdoors beyond the optimal thresholds (e.g., more than three hours in summer for PhenoAge) was associated with an increase in biological age acceleration. This suggests a U-shaped relationship where moderate exposure is ideal.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ning JD et al. Association between time spent outdoors during the day and biological age acceleration among UK Biobank participants. Int J Environ Health Res. 2026 Feb 14. doi: 10.1080/09603123.2026.2630856. PMID: 41689427.
Yang G et al. Association of unhealthy lifestyle and childhood adversity with acceleration of aging among UK Biobank participants. JAMA Netw Open. 2022;5(9):e2230690. doi:10.1001/jamanetworkopen.2022.30690.
Liu Z et al. A new aging measure, phenotypic age, predicts mortality and healthspan in diverse cohorts. Aging (Albany NY). 2018;10(12):3821-3840. doi:10.18632/aging.101723.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study identifies optimal outdoor time to prevent biological age acceleration, recommending two hours in summer and one hour in winter for healthy aging....
6 months ago

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday

A comprehensive meta-analysis shows digital health technologies significantly improve 6-minute walk distance and peak oxygen uptake in chronic heart failure patients, highlighting the clinical promise of structured remote cardiac rehabilitation.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

A comprehensive analysis of continuous glucose monitoring systems under European Medical Device Regulation 2017/745, examining conformity assessment challenges, Notified Body backlogs, EUDAMED rollout delays, and the critical need for transparent post-market surveillance.
Today